Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein

Abstract

P-glycoprotein (P-gp or ABCB1) is a member of the broad family of ABC transporters. P-gp participates in the establishment of physiological barriers limiting cellular access of a large number of toxic compounds. It thus plays important roles in the pharmacokinetics of these compounds. Cancer cells and cells infected by viruses exploit the presence of P-gp to fend off drug treatment, rendering them multidrug-resistant. Overcoming multidrug resistance caused by expression of ABC transporters has gained increasing attention in the field of drug development. Recently, studies of P-gp, especially from structural investigations by both cryo-electron microscopy and X-ray crystallography, have provided high-resolution mechanistic details for the function of this transporter. Structures with increasing resolution and accuracy in various substrate- and inhibitor-bound forms are available for analysis and a consensus on the mechanism of substrate polyspecificity is emerging. The use of new structural information may aid development of P-gp inhibitors as well as compounds that may bypass P-gp action.

Keywords

P-glycoprotein / multidrug resistance / substrate polyspecificity / structure / ABC transporter

References

[1] Gillet JP.Mechanisms of multidrug resistance in cancer..Methods Mol Biol2010;596:47-76

[2] Gottesman MM.The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research..FEBS Lett2006;580:998-1009

[3] Gottesman MM.The multidrug transporter, a double-edged sword..J Biol Chem1988;263:12163-6

[4] Dano K.Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo..Cancer Chemother Rep1972;56:701-8

[5] Kessel D,Wodinsky I.Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response..Cancer Res1968;28:938-41

[6] Ling V.Reduced permeability in CHO cells as a mechanism of resistance to colchicine..J Cell Physiol1974;83:103-16

[7] Dano K.Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells..Biochim Biophys Acta1973;323:466-83

[8] See YP,Till JE.Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide..Biochim Biophys Acta1974;373:242-52

[9] Juliano RL.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants..Biochim Biophys Acta1976;455:152-62

[10] Riordan JR.Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability..J Biol Chem1979;254:12701-5

[11] Robertson SM,Stanners CP.Co-amplification of double minute chromosomes, multiple drug resistance, and cell surface P-glycoprotein in DNA-mediated transformants of mouse cells..Mol Cell Biol1984;4:500-6 PMCID:PMC368728

[12] Scotto KW.Transcriptional regulation of ABC drug transporters..Oncogene2003;22:7496-511

[13] Fojo AT,Slamon DJ,Gottesman MM.Expression of a multidrug-resistance gene in human tumors and tissues..Proc Natl Acad Sci U S A1987;84:265-9 PMCID:PMC304184

[14] Beck WT,Tanzer LR.Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts..Cancer Res1979;39:2070-6

[15] Kartner N,Ling V.Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines..Science1983;221:1285-8

[16] Ueda K,Gottesman MM,Roninson IB.The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein..Biochem Biophys Res Commun1986;141:956-62

[17] Bell DR,Kartner N,Ling V.Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance..J Clin Oncol1985;3:311-5

[18] Tsuruo T,Tsukagoshi S.Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil..Cancer Res1981;41:1967-72

[19] List AF,Willman CL,Persons DL.Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study..Blood2001;98:3212-20

[20] Sugawara I,Morishita Y,Tsuruo T.Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16..Cancer Res1988;48:1926-9

[21] Tatsuta T,Oh-hara T,Tsuruo T.Functional involvement of P-glycoprotein in blood-brain barrier..J Biol Chem1992;267:20383-91

[22] Sparreboom A,Mayer U,Smit JW.Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine..Proc Natl Acad Sci U S A1997;94:2031-5 PMCID:PMC20037

[23] Schinkel AH,van Tellingen O,Wagenaar E.Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barier and to increased sensitivity to drugs..Cell1994;77:491-502

[24] Chen CJ,Ueda K,Pastan I.Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells..Cell1986;47:381-9

[25] Gerlach JH,Juranka PF,Sarangi F.Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance..Nature1986;324:485-9

[26] Gros P,Croop JM.Isolation and expression of a complementary DNA that confers multidrug resistance..Nature1986;323:728-31

[27] Roninson IB,Choi KG,Housman DE.Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells..Proc Natl Acad Sci U S A1986;83:4538-42 PMCID:PMC323769

[28] Hamada H.Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase..J Biol Chem1988;263:1454-8

[29] Germann UA,Pastan I.Expression of the human multidrug transporter in insect cells by a recombinant baculovirus..Biochemistry1990;29:2295-03

[30] Horio M,Pastan I.ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells..Proc Natl Acad Sci U S A1988;85:3580-4 PMCID:PMC280257

[31] Ambudkar SV,Zhang J,Gottesman MM.Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis..Proc Natl Acad Sci U S A1992;89:8472-6 PMCID:PMC49942

[32] Sarkadi B,Boucher RC,Scarborough GA.Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase..J Biol Chem1992;267:4854-8

[33] al-Shawi MK.Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein..J Biol Chem1993;268:4197-06

[34] Urbatsch IL,Carrier I.Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites..Biochemistry1998;37:4592-602

[35] Omote H,Polar MK.Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation..Biochemistry2004;43:3917-28

[36] Urbatsch IL,Weber J.P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site..J Biol Chem1995;270:19383-90

[37] Senior AE,Urbatsch IL.The catalytic cycle of P-glycoprotein..FEBS Lett1995;377:285-9

[38] Loo TW.Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates..J Biol Chem1996;271:27482-7

[39] Loo TW.Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate..J Biol Chem1997;272:31945-8

[40] Loo TW.Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane..J Biol Chem1999;274:35388-92

[41] Loo TW.Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane..J Biol Chem2000;275:39272-8

[42] Loo TW.Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil..J Biol Chem2001;276:14972-9

[43] Bruggemann EP,Gottesman MM.Characterization of the azidopine and vinblastine binding site of P-glycoprotein..J Biol Chem1992;267:21020-6

[44] Dey S,Pastan I,Ambudkar SV.Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein..Proc Natl Acad Sci U S A1997;94:10594-9 PMCID:PMC23414

[45] Martin C,Higgins CF,Charlton P.Communication between multiple drug binding sites on P-glycoprotein..Mol Pharmacol2000;58:624-32

[46] Jin MS,Zhang Q.Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans..Nature2012;490:566-9 PMCID:PMC3482266

[47] Higgins CF.Is the multidrug transporter a flippase?.Trends Biochem Sci1992;17:18-21

[48] Homolya L,Germann UA,Gottesman MM.Fluorescent cellular indicators are extruded by the multidrug resistance protein..J Biol Chem1993;268:21493-6

[49] Raviv Y,Bruggemann EP,Gottesman MM.Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells..J Biol Chem1990;265:3975-80

[50] Ramachandra M,Chen D,Dey S.Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state..Biochemistry1998;37:5010-9

[51] Loo TW.Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux..J Membr Biol2005;206:173-85

[52] Qu Q.FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated..Biochemistry2001;40:1413-22

[53] Sauna ZE,Nandigama K,Chiba P.Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP..Biochemistry2007;46:13787-99

[54] Zoghbi ME,Swartz DJ,Fendley GA.Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis..J Biol Chem2017;292:20412-24 PMCID:PMC5733581

[55] Patzlaff JS,Poolman B.The ATP/substrate stoichiometry of the ATP-binding cassette (ABC) transporter OpuA..J Biol Chem2003;278:29546-51

[56] Sauna ZE,Peng XH.Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1)..Biochemistry2002;41:13989-4000

[57] Krupka RM.Uncoupled active transport mechanisms accounting for low selectivity in multidrug carriers: P-glycoprotein and SMR antiporters..J Membr Biol1999;172:129-43

[58] van Veen HW,Muller M,Konings WN.The homodimerric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism..EMBO J2000;19:2503-14 PMCID:PMC212756

[59] Higgins CF.The ATP switch model for ABC transporters..Nat Struct Mol Bio2004;11:918-26

[60] Jardetzky O.Simple allosteric model for membrane pumps..Nature1966;211:969-70

[61] Hrycyna CA,Ambudkar SV,Pedersen PL.Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites..J Biol Chem1998;273:16631-4

[62] Tombline G,Tyndall GA,Urbatsch IL.Properties of P-glycoprotein with mutations in the "catalytic carboxylate" glutamate residues..J Biol Chem2004;279:46518-26

[63] Urbatsch IL,Bhagat S.Both P-glycoprotein nucleotide-binding sites are catalytically active..J Biol Chem1995;270:26956-61

[64] Aller SG,Ward A,Chittaboina S.Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding..Science2009;323:1718-22 PMCID:PMC2720052

[65] Li J,Aller SG.Refined structures of mouse P-glycoprotein..Protein Sci2014;23:34-46 PMCID:PMC3892297

[66] Esser L,Pluchino KM,Ma J.Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity..J Biol Chem2017;292:446-61 PMCID:PMC5241723

[67] Dawson RJ.Structure of a bacterial multidrug ABC transporter..Nature2006;443:180-5

[68] Reyes CL.Lipopolysaccharide stabilizes the crystal packing of the ABC transporter MsbA..Acta Crystallograph Sect F Struct Biol Cryst Commun2005;61:655-8 PMCID:PMC1952464

[69] Kim Y.Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation..Science2018;359:915-9

[70] Alam A,Broude E,Locher KP.Structural insight into substrate and inhibitor discrimination by human P-glycoprotein..Science2019;363:753-6

[71] Alam A,Kowal J,Tremp N.Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1..Proc Natl Acad Sci U S A2018;115:E1973-82 PMCID:PMC5834697

[72] Kodan A,Nakatsu T,Hipolito CJ.Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog..Proc Natl Acad Sci U S A2014;111:4049-54 PMCID:PMC3964115

[73] Ward A,Yu J,Chang G.Flexibility in the ABC transporter MsbA: Alternating access with a twist..Proc Natl Acad Sci U S A2007;104:19005-10 PMCID:PMC2141898

[74] Ward AB,Grimard V,Martinez L.Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain..Proc Natl Acad Sci U S A2013;110:13386-91 PMCID:PMC3746859

[75] Szewczyk P,McGrath AP,Rees SD.Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein..Acta Crystallogr D Biol Crystallogr2015;71:732-41 PMCID:PMC4356375

[76] Nicklisch SC,McGrath AP,Bonito LT.Global marine pollutants inhibit P-glycoprotein: environmental levels, inhibitory effects, and cocrystal structure..Sci Adv2016;2:e1600001 PMCID:PMC4846432

[77] Khare D,Orelle C,Chen J.Alternating access in maltose transporter mediated by rigid-body rotations..Mol Cell2009;33:528-36 PMCID:PMC2714826

[78] Hrycyna CA,Germann UA,Pastan I.Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport..Biochemistry1998;37:13660-73

[79] Sato T,Kimura Y,Nakatsu T.Functional role of the linker region in purified human P-glycoprotein..FEBS J2009;276:3504-16

[80] Chen J.Molecular mechanism of the Escherichia coli maltose transporter..Curr Opin Struct Biol2013;23:492-8 PMCID:PMC3743091

[81] Locher KP.Review. Structure and mechanism of ATP-binding cassette transporters..Philos Trans R Soc Lond B Biol Sci2009;364:239-45 PMCID:PMC2674090

[82] Verhalen B,Thangapandian S,Koteiche HA.Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein..Nature2017;543:738-41 PMCID:PMC5558441

[83] Hrycyna CA,Germann UA,Pastan I.Both ATP sites of human P-glycoprotein are essential but not symmetric..Biochemistry1999;38:13887-99

[84] Loo TW.Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity..J Biol Chem1995;270:22957-61

[85] Sankaran B,Senior AE.Inhibition of P-glycoprotein ATPase activity by beryllium fluoride..Biochemistry1997;36:6847-53

[86] Tombline G,Gimi K,Senior AE.Synergy between conserved ABC signature Ser residues in P-glycoprotein catalysis..J Biol Chem2004;279:5363-73

[87] Li MJ,Atkins WM.Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale..J Biol Chem2018;293:6297-307 PMCID:PMC5925813

[88] Tombline G,Urbatsch IL.Combined mutation of catalytic glutamate residues in the two nucleotide binding domains of P-glycoprotein generates a conformation that binds ATP and ADP tightly..J Biol Chem2004;279:31212-20

[89] Loo TW.Identification of the distance between P-glycoprotein's homologous halves that triggers the high/low ATPase activity switch..J Biol Chem2014;289:8484-92 PMCID:PMC3961673

[90] Wen PC,Wilkens S,Tajkhorshid E.On the Origin of Large Flexibility of P-glycoprotein in the Inward-Facing State..J Biol Chem2013;288:19211-20 PMCID:PMC3696692

[91] Loo TW,Clarke DM.Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein..J Biol Chem2003;278:39706-10

[92] Frank GA,Rao P,Bartesaghi A.Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle..Mol Pharmacol2016;90:35-41 PMCID:PMC4931865

[93] Moeller A,Tao H,Chang G.Distinct conformational spectrum of homologous multidrug ABC transporters..Structure2015;23:450-60 PMCID:PMC4351144

[94] Sigdel KP,Marsh BP,King GM.The conformation and dynamics of P-glycoprotein in a lipid bilayer investigated by atomic force microscopy..Biochem Pharmacol2018;156:302-11

[95] Choudhury HG,Mathavan I,Iwata S.Structure of an antibacterial peptide ATP-binding cassette transporter in a novel outward occluded state..Proc Natl Acad Sci U S A2014;111:9145-50 PMCID:PMC4078857

[96] Smith PC,Millen L,Rosen J.ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer..Mol Cell2002;10:139-49 PMCID:PMC3516284

[97] Siarheyeva A,Sharom FJ.Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis..J Biol Chem2010;285:7575-86 PMCID:PMC2844205

[98] Loo TW.Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix..J Biol Chem2001;276:31800-5